I agree that this site is using cookies. You can find further informations here.
X
Isla, Arantxazu
65  results:
Search for persons X
?
1

Optimization of levetiracetam dosing regimen in critically ..:

Bilbao-Meseguer, Idoia ; Barrasa, Helena ; Rodríguez-Gascón, Alicia...
Journal of Intensive Care.  10 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
2

Quantification of Ceftaroline in Human Plasma Using High-Pe..:

Alarcia-Lacalle, Ana ; Barrasa, Helena ; Maynar, Javier...
Pharmaceutics.  13 (2021)  7 - p. 959 , 2021
Link: https://doi.org/10.3390/..
 
?
3

Pharmacokinetic/pharmacodynamic evaluation of the antimicro..:

Ibar-Bariain, Maitane ; Isla, Arantxazu ; Solinís, María Ángeles...
European Journal of Clinical Microbiology & Infectious Diseases.  40 (2021)  10 - p. 2145-2152 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Impact of augmented renal clearance on the pharmacokinetics..:

Barrasa, Helena ; Soraluce, Amaia ; Usón, Elena...
International Journal of Infectious Diseases.  93 (2020)  - p. 329-338 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Gene-terapia: Ikuspegi terapeutiko berria begietako gaitzen..:

Rodríguez-Castejón, Julen ; Gómez-Aguado, Itziar ; Vicente-Pascual, Mónica...
EKAIA Euskal Herriko Unibertsitateko Zientzia eta Teknologia Aldizkaria.  , 2020
Link: https://doi.org/10.1387/..
 
?
6

Novel Population Pharmacokinetic Model for Linezolid in Cri..:

Soraluce, Amaia ; Barrasa, Helena ; Asín-Prieto, Eduardo...
Pharmaceutics.  12 (2020)  1 - p. 54 , 2020
Link: https://doi.org/10.3390/..
 
?
7

Pharmacokinetics of linezolid in critically ill patients on..:

Barrasa, Helena ; Soraluce, Amaia ; Isla, Arantxazu...
Journal of Critical Care.  50 (2019)  - p. 69-76 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Augmented Renal Clearance in Critically Ill Patients: A Sys..:

Bilbao-Meseguer, Idoia ; Rodríguez-Gascón, Alicia ; Barrasa, Helena..
Clinical Pharmacokinetics.  57 (2018)  9 - p. 1107-1121 , 2018
Link: https://doi.org/10.1007/..
 
?
9

Nanostructured lipid carriers as oral delivery systems for ..:

Beloqui, Ana ; del Pozo-Rodríguez, Ana ; Isla, Arantxazu..
Journal of Drug Delivery Science and Technology.  42 (2017)  - p. 144-154 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Applications of the pharmacokinetic/pharmacodynamic (PK/PD)..:

Asín-Prieto, Eduardo ; Rodríguez-Gascón, Alicia ; Isla, Arantxazu
Journal of Infection and Chemotherapy.  21 (2015)  5 - p. 319-329 , 2015
Link: https://doi.org/10.1016/..
 
?
11

Anticholinergic burden in Parkinson's disease inpatients:

Lertxundi, Unax ; Isla, Arantxazu ; Solinis, Maria Angeles...
European Journal of Clinical Pharmacology.  71 (2015)  10 - p. 1271-1277 , 2015
Link: https://doi.org/10.1007/..
 
?
12

Population pharmacokinetic models for cefuroxime and metron..:

Asín-Prieto, Eduardo ; Soraluce, Amaia ; Trocóniz, Iñaki F....
International Journal of Antimicrobial Agents.  45 (2015)  5 - p. 504-511 , 2015
Link: https://doi.org/10.1016/..
 
?
13

A Proposal to Prevent Omissions and Delays of Antiparkinson..:

Lertxundi, Unax ; Isla, Arantxazu ; Solinis, Ma Angeles...
The Neurohospitalist.  5 (2015)  2 - p. 53-54 , 2015
Link: https://doi.org/10.1177/..
 
?
14

Vaginal gene therapy:

Rodríguez-Gascón, Alicia ; del Pozo-Rodríguez, Ana ; Isla, Arantxazu.
Advanced Drug Delivery Reviews.  92 (2015)  - p. 71-83 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Population pharmacokinetics of prophylactic cefoxitin in pa..:

Isla, Arantxazu ; Trocóniz, Iñaki F. ; de Tejada, Ignacio López...
European Journal of Clinical Pharmacology.  68 (2012)  5 - p. 735-745 , 2012
Link: https://doi.org/10.1007/..
 
1-15